In these individuals, blended agonist/antagonist and partial agonist analgesics may perhaps lessen the analgesic effect and/or may precipitate withdrawal indications.But OxyContin has become continued for use to deal with people who're struggling from average to extreme suffering arising from terminal ailments including most cancers or recovery fro